HCW Biologics Inc. HCWB
1.08 USD -0.07 (-6.09%)
At closeNov 5, 2026, 5:05 AM EST
1.09 +0.01 +0.93%
Pre-market · Nov 5, 5:05 AM ET
1.08 Day range 1.15
1.08 52-week range 23.94
- YTD
- -81.48%
- 1 year
- -94.71%
Financial health
Altman Z-Score
-6.89 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 5
Valuation
P/E -0.1×
FY 2019 5y median -70.3× FY 2025
P/S 37.5×
FY 2019 5y median 270× FY 2025
P/B 0.7×
FY 2019 5y median 64.8× FY 2025
P/FCF -0.2×
FY 2019 5y median -61.6× FY 2025
EV/EBITDA -1.2×
FY 2019 5y median -75.1× FY 2025
EV/Sales 127×
FY 2019 5y median 273× FY 2025
FCF Yield -658.1%
FY 2019 5y median -1.6% FY 2025
Profitability
Gross Margin 20.0%
FY 2019 5y median 20.0% FY 2025
Operating Margin -20757.6%
FY 2019 5y median -905.0% FY 2025
Net Margin -14677.1%
FY 2019 5y median -879.5% FY 2025
ROE -287.9%
FY 2019 5y median -39.8% FY 2025
ROIC -109.7%
FY 2019 5y median -109.7% FY 2025
ROA -32.5%
FY 2019 5y median -32.5% FY 2025
Growth (YoY)
Revenue -97.9%
FY 2019 FY 2025
Operating Income 61.8%
FY 2019 FY 2025
EPS (diluted) -1280.5%
FY 2019 FY 2025
Free Cash Flow 7.6%
FY 2019 FY 2025
Financial Health
Current Ratio 0.1×
FY 2019 5y median 0.7× FY 2025
Quick Ratio 0.1×
FY 2019 5y median 0.7× FY 2025
Debt / Equity 2.5×
FY 2019 5y median 0.2× FY 2025
Net Debt / EBITDA -0.9×
FY 2019 5y median -0.1× FY 2025
Interest Coverage -9.0×
FY 2019 5y median -25.4× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31